EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal evidence for the association between muscle mass and NAFLD: insights from hospital-based data, NHANES and mendelian randomization

Weidong Xie, Sen Li, Shaoliang Han

Frontiers in Genetics · 26.05.2026 · 17

DOI: 10.3389/fgene.2026.1821445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 26.05.2026. Verfasst von Weidong Xie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head and Neck Surgery, Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing, China. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sarcopenia has been suggested as a potential risk factor for non-alcoholic fatty liver disease (NAFLD), but the causal relationship remains unclear.

Methods

We conducted a multimodal study combining hospital-based data, population survey, and Mendelian randomization (MR). A total of 2,384 patients with acute appendicitis (2016–2025) were analyzed using appendicular skeletal muscle mass index (ASMI) as a sarcopenia marker and CT-defined NAFLD as outcome. Logistic regression and SIMEX correction were applied. The association was validated in 21,696 NHANES participants (1999–2018) using the United States Fatty Liver Index (USFLI) and double-SIMEX correction. Finally, two-sample and multivariable MR were performed using GWAS summary data.

Results

Higher muscle mass was consistently associated with a lower NAFLD risk in hospital-based (OR = 0.16, 95% CI 0.03–0.82, P = 0.03) and NHANES populations (OR = 0.02, 95% CI 0.01–0.04, P < 0.001). MR analyses suggested a potential causal inverse relationship (OR = 0.91, 95% CI 0.84–0.99, P = 0.01), independent of BMI, cholesterol, and triglycerides (OR = 0.82, 95% CI 0.72–0.94, P = 0.003).

Conclusion

This multimodal evidence suggested low muscle mass as a causal risk factor for NAFLD. Interventions that maintain or increase muscle mass may reduce NAFLD risk.

Schlagwörter

Stichwörter der Autor:innen

NHANESmendelian randomizationnon-alcoholic fatty liver diseasesarcopeniaskeletal muscle mass

Autor:innen und Institutionen

  • Department of Head and Neck Surgery, Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing, China.
  • School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Zitieren

APA

Xie, W., Li, S., & Han, S. (2026). Multimodal evidence for the association between muscle mass and NAFLD: insights from hospital-based data, NHANES and mendelian randomization. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1821445

Vancouver

Xie W, Li S, Han S. Multimodal evidence for the association between muscle mass and NAFLD: insights from hospital-based data, NHANES and mendelian randomization. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1821445

BibTeX
@article{Xie2026,
  author = {Xie, Weidong and Li, Sen and Han, Shaoliang},
  title = {Multimodal evidence for the association between muscle mass and NAFLD: insights from hospital-based data, NHANES and mendelian randomization},
  journal = {Frontiers in Genetics},
  year = {2026},
  volume = {17},
  doi = {10.3389/fgene.2026.1821445}
}
Kostenlos starten →